Inlyta (axitinib) Approved For Advanced Kidney Cancer, USA Medical News Today The US FDA has approved Inlyta (axitinib) for the treatment of advanced renal cell carcinoma, a type of kidney cancer, in patients with whom other drugs have not been effective, the FDA (Food and Drug Administration) announced today.

...